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Control of Perfusable Microvascular Network Morphology
Using a Multiculture Microfluidic System
Jordan A. Whisler, MS,1 Michelle B. Chen, BS,1 and Roger D. Kamm, PhD1,2
The mechanical and biochemical microenvironment influences the morphological characteristics of microvas-
cular networks (MVNs) formed by endothelial cells (ECs) undergoing the process of vasculogenesis. The ob-
jective of this study was to quantify the role of individual factors in determining key network parameters in an
effort to construct a set of design principles for engineering vascular networks with prescribed morphologies. To
achieve this goal, we developed a multiculture microfluidic platform enabling precise control over paracrine
signaling, cell-seeding densities, and hydrogel mechanical properties. Human umbilical vein endothelial cells
(HUVECs) were seeded in fibrin gels and cultured alongside human lung fibroblasts (HLFs). The engineered
vessels formed in our device contained patent, perfusable lumens. Communication between the two cell types
was found to be critical in avoiding network regression and maintaining stable morphology beyond 4 days. The
number of branches, average branch length, percent vascularized area, and average vessel diameter were found
to depend uniquely on several input parameters. Importantly, multiple inputs were found to control any given
output network parameter. For example, the vessel diameter can be decreased either by applying angiogenic
growth factors—vascular endothelial growth factor (VEGF) and sphingosine-1-phsophate (S1P)—or by in-
creasing the fibrinogen concentration in the hydrogel. These findings introduce control into the design of MVNs
with specified morphological properties for tissue-specific engineering applications.
Introduction
Engineered biological tissue for implantation and re-generative therapies requires a functional microvascula-
ture to ensure proper function and survival in its intended
working environment. It is likely that the desired microvas-
cular network (MVN) morphology of an engineered tissue
will vary depending on its ultimate function in the body.
This can be inferred from the significant differences found in
the microvasculature of various organs in vivo and across
species.1 For instance, islet cells cannot survive separation
distances from the nearest capillary greater than 0.1mm due
to insufficient diffusion of oxygen, whereas chondrocytes in
cartilage tissue can survive distances exceeding 1mm.2 By
controlling the diameter of engineered microvessels and the
branching characteristics of their networks, the optimal
perfusion rate and separation distance for a specific tissue
can be achieved. Along these lines, Hoganson et al.3 applied a
biomimetic design approach to the tissue-specific microvas-
cular requirements of the liver to reproduce physiological
blood flow characteristic for that organ. Additionally, many
mathematical models—originating with the theory set forth
by Murray,4 based on the principle of minimum work—have
been developed to determine the optimal design of a
MVN.1,5–7 However, these designs have generally been im-
plemented in the form of preformed vascular molds, which
are subsequently seeded with endothelial cells (ECs)8 and
thus do not mimic the complex process of vascular network
formation in vivo. There has been remarkable progress re-
cently in forming perfusable MVNs in three-dimensional
hydrogels without the need for artificial architecture to
support the vascular structures.9–12 Still lacking, however, is
a systematic study of the factors controlling the network
morphology and the effects of signaling between different
cell types.
Moreover, the dominating influence determining network
morphology is generally assumed to consist of fluid flow
dynamics and related shear forces acting on the endothe-
lium. However, it has long been recognized that mechanical
and biochemical properties of the microenvironment can
also play important roles in determining MVN morphology.
The goal of our research was, therefore, to probe the bio-
chemical and mechanical environment of ECs undergoing
the process of vasculogenesis in a three-dimensional hy-
drogel to determine the influence of these factors on the
morphological characteristics of the resulting engineered
MVNs. By uncovering these design principles, we are able
to take advantage of the natural control mechanisms em-
ployed in vivo to guide MVN formation toward a desired
morphology.
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To achieve this goal, we used a multiculture perfusable
microfluidic platform enabling real-time observation and
independent control over paracrine signaling, cell-seeding
densities, and hydrogel mechanical properties (Fig. 1A, B).
Human umbilical vein endothelial cells (HUVECs) were
seeded in fibrin gels and cultured alongside—but not in
contact with—human lung fibroblasts (HLFs). HUVECs
spontaneously formed networks within 24 h and the en-
gineered vessels contained patent, perfusable lumens as
demonstrated by the passage of fluorescent microspheres
FIG. 1. (A) Top view diagram of multiculture microfluidic device containing three parallel gel regions for encapsulation of
endothelial and stromal cells. Gel regions (B, C) are separated by medium channels (A) for gas exchange and delivery of
nutrients. (B) A cross-sectional view diagram of multiculture microfluidic device. Cell culture region is surrounded by PDMS
above and glass coverslip below (not to scale). (C) Top view of perfusable vessels opening to medium channel on left. Region
shown is between two PDMS trapezoidal posts. Twenty such regions exist in each microfluidic device. Staining: Green–
phalloidin; Blue–DAPI (same for D–G). Scale bar = 100 mm. (D) A 10 · confocal image of perfusable microvascular network
(MVN) grown in a multiculture microfluidic device. Scale bar = 100 mm. (E) Full image of vascularized gel region. White box
corresponds to enlarged image in (F). Scale bar = 1mm. (F) Sequence of four section views taken throughout 20 · confocal
stack. Vertical cross sections on the bottom and right correspond to the location of the white crosshairs. As the cross sections
progress through the vascularized region, patent lumens are seen to vary in location and diameter, but remain continuous
throughout the gel. This demonstrates the existence of perfusable vessels spanning the 100 mm height of the gel region.
Further validation of perfusability is provided in the Supplementary videos. Scale bar = 100mm. (G) A 40· confocal image
of a segment of perfusable microvessel showing multiple cells. Scale bar = 10mm. See Supplementary video SV1 for three-
dimensional rendering with visualization of lumen. Color images available online at www.liebertpub.com/tec
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after 4 days (Supplementary Videos SV2 and SV3; Supple-
mentary Data are available online at www.liebertpub.com/
tec). Communication between the two cell types was nec-
essary to avoid network regression and maintain stable
morphology beyond 4 days. Fluorescent imaging and
subsequent analysis were used to quantify the number of
branches, average branch length, percent vascularized area,
and average vessel diameter of the MVNs generated under
various conditions. Finally, results were tabulated and the
design parameter space was mapped out for the conditions
studied.
This study provides quantitative results for direct use in
the design of engineered MVNs. It also demonstrates the
powerful capabilities of miniaturized, perfusable, three-
dimensional engineered MVNs to study the influence of a
multitude of environmental cues affecting network mor-
phology in a high-throughput and readily observable man-
ner. It more generally demonstrates the ability to approach
microvascular tissue engineering as a design problem using
systematic, quantitative analysis.
Materials and Methods
Device design and fabrication
A standard procedure for generating silicone molds was
used.13 Briefly, computer aided designs (CAD) were gener-
ated and used to print negative pattern transparency masks.
A 100 mm layer of SU-8 photoresist was coated onto a silicon
wafer, and the mask was used to photopolymerize the pat-
tern on to the wafer.
The mask was repeatedly used to form microfluidic chips.
Briefly, PDMS (Ellsworth Adhesives) and a curing agent
were mixed at a 10:1 ratio and poured onto the wafer. After
degassing, the PDMS was baked in an 80C oven for 2 h. The
individual devices were then cut out and a biopsy punch
was used to create ports for gel filling and medium channels.
Tape was used to remove dust from the surface, and the
devices were placed in an autoclave for sterilization. Clean
devices and coverslips were plasma treated (Harrick Plasma)
and bonded together.
The design of this multiculture vasculogenesis device was
based on earlier designs from our laboratory14 with some
important adjustments: (1) a third parallel gel region was
included so that stromal cells could be cultured on either side
of the vascularized gel region, (2) additional medium chan-
nels were included so that each gel region is flanked by two
medium channels—one on each side—to provide adequate
gas exchange and supply of nutrients, and (3) the length
of the device was increased to provide a larger region for
vascularization.
The width of each gel and medium channel was chosen to
be 1.3mm. This was to ensure that the vascularized region’s
maximum dimension was at least 1mm, such that diffusion
is insufficient for delivering nutrients and removing wastes
from the inner core of a living tissue. This is the length scale
for which prevascularization is necessary.15 The width as
well as the length of the gel region could be increased to
provide a larger vascularized area without affecting the dy-
namics of the system. Since the ECs and HLFs communicate
through diffusive transport of secreted factors, the width of
the medium channel determines the time scale for this pro-
cess to occur. For typical growth factors, the time constant for
diffusion over a length of 1mm is on the order of several
hours. Since the process of network formation studied in our
system occurs over a period of days, this width is sufficiently
small to ensure adequate time for diffusion to occur. Because
the necessary time for diffusion scales with the square of the
distance between the gel regions, the width of the medium
channel should not be increased. Finally, the dimensions of
the fibroblast gel region, in combination with cell seeding
density, determine the rate of secretion of growth factors and
cytokines. We chose dimensions that enabled us to screen for
the optimal seeding ratio between HUVECs and NHLFs
within a range of 1:2–2:1 that is physiologically relevant
and reported in other in vitro studies16,17 (Results discussed
below).
To achieve optimal imaging conditions, we chose a height
of 100mm for the device and sealed it with a glass coverslip.
This height enabled us to form generally planar perfusable
networks, allowing us to capture the MVN morphological
patterns from a single focal plane using epifluorescence. The
height could be increased for clinical applications, in which it
might be desirable to form vascularized tissue constructs
containing several planes of vessels.
Cell culture
HUVECs (Lonza) were cultured on collagen I-coated
flasks (50 mg/mL collagen solution in ascetic acid for 30min;
BD Biosciences) in EGM-2 MV (Lonza) growth medium and
used in experiments between passages 6–8. Normal human
lung fibroblasts (NHLF; Lonza) were cultured in FBM-2
(Lonza) growth medium and used in experiments between
passages 6–10.
For exogenous growth factor experiments, EGM-2 MV
growth medium was supplemented with 50 ng/mL VEGF
(Peprotech) and 250 nM S1P (Sigma). The medium was re-
plenished every 2 days.
Fibrin gel cell encapsulation
Fibrinogen (Sigma) was dissolved in PBS (Lonza) at twice
the final concentration (2.5–20mg/mL for fibrin concentra-
tion experiments). Thrombin (Sigma) was dissolved in PBS at
2U/mL. These solutions were mixed, over ice, at a 1:1 ratio
to produce a final fibrinogen solution with the desired con-
centration (1.25–10mg/mL). The mixture was quickly pi-
petted into the device using the gel filling ports. The device
was placed in a humidified enclosure and allowed to poly-
merize at room temperature for 10min before fresh growth
medium was introduced to the medium channels. The
growth medium was replaced every 2 days.
For gels with encapsulated cells, a similar procedure was
followed. Cells were spun down at 1200 rpm for 5min and
the cell pellet was resuspended in EGM-2 MV growth me-
dium containing 2U/mL of thrombin and mixed with the
fibrinogen solution at a 1:1 ratio. The device was placed in a
humidified enclosure and allowed to polymerize at room
temperature for 10min before fresh growth medium was
introduced to the medium channels.
Staining/imaging
After 4 days, cells in devices were fixed with 4% para-
formaldehyde (Electron Microscopy Sciences) for 15min and
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rinsed 3·with PBS. Triton X (0.1%; Sigma) was then intro-
duced to permeabilize the cells and rinsed 3·with PBS after
15min. The devices were then treated with DAPI and phal-
loidin (Life Technologies) for 2 h to stain the nuclei and actin,
respectively. Phalloidin staining was used to image vascular
network morphology with an epifluorescent microscope
(Nikon Eclipse Ti-S; Nikon Instruments, Inc.). Confocal im-
ages were taken with an Olympus IX81 microscope (Olym-
pus America, Inc.).
Analysis/quantification
The procedure used to process and analyze fluorescent
images is described in detail elsewhere.18 Briefly, raw images
were prepared by enhancing contrast and removing noise.
Automatic thresholding was used to binarize the images.
Unconnected segments, which were not part of the perfu-
sable networks, were automatically removed from the im-
ages. Finally, networks were skeletonized and analyzed19
using ImageJ software (http://rsbweb.nih.gov/ij/).
Effective diameter calculations were performed by divid-
ing the thresholded vascularized area by the entire length of
the skeletonized network.
For perfusability experiments with fibroblasts, the regions
between PDMS posts containing vessels opening to the ad-
jacent medium channels were counted and expressed as a
percentage of the total number of regions.
Bead flow experiments
For bead flow experiments, vascular networks were fixed
and stained as described above. Ten micrometer fluorescent
microspheres (Life Technologies) were perfused through the
networks by imposing a hydrostatic pressure drop across the
EC gel region. Videos were recorded using NIS-Elements
software (Nikon Instruments, Inc.) on a Nikon Eclipse Ti-S
microscope (Nikon Instruments, Inc.) at a frame rate of 3.37
frames per second.
Statistical analysis
All data shown represent experiments with at least n= 3
individual microfluidic devices. Reported values correspond
to averages over these devices for any given condition. Error
bars were calculated using standard error. Significance was
calculated using a two-tailed Student’s t test and p-values are
supplied in the Supplementary Tables S1–S6.
Results
Fibroblast stabilization
In initial experiments, we used a microfluidic device with a
single gel region seeded with ECs alone (data not shown). ECs
alone did form vascular networks after 2 days of culture.
However, these networks subsequently regressed with time. It
has been shown that coculture with fibroblasts enhances mi-
crovascular network formation in sprouting angiogenesis,20,21
vasculogenesis,10 and in mixed coculture experiments.11 We
suspected that fibroblasts in noncontact coculture might also
be important in stabilizing the nascent vascular networks be-
fore they regress. Using the revised multiculture version of
our microfluidic device to encapsulate fibroblasts in the ad-
jacent gel regions, we indeed found that the presence of fi-
broblasts effectively stabilized the MVNs as measured by the
total vascularized area and network perfusability (Fig. 2). In
the case of monoculture, these properties gradually decreased
after initial network formation, consistent with our prelimi-
nary experiments. However, under coculture conditions, they
reached a stable plateau after 4 days.
Paracrine signaling
In an attempt to recapitulate the stabilizing effects of the
fibroblasts, proangiogenic growth factors—VEGF (50 ng/
mL) and S1P (250 nM)—were added to the growth medium.
We chose these growth factors and specific concentrations
based on previous work in our laboratory in which they
FIG. 2. (A) Phase contrast images
(4 · ) of MVNs formed by en-
dothelial cells (ECs) in isolated
monoculture with EGM-2 MV me-
dium (control) or in fibroblast co-
culture with EGM-2 MV medium.
After day 4, control networks re-
gress, while coculture networks re-
main intact. Scale bar = 1mm. (B)
Area covered by MVNs under
monoculture and coculture condi-
tions over a 6-day period. Values
given are averages over at least
three devices with error bars given
as standard error (same for C, D).
(C) Percentage of perfusable seg-
ments as defined by vascularized
gel regions opening to medium
channel containing at least one
patent lumen. (D) Perfusable seg-
ments at day 6 as a function of fi-
broblast seeding density.
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enhanced vessel sprouting and lumen formation in an an-
giogenesis model.18 These growth factors did not signifi-
cantly improve the long-term stability of the networks.
However, they did give rise to vascular networks with sig-
nificantly different morphological characteristics (Fig. 3). The
resulting networks contained more branches with shorter
average length and smaller diameters than those cultured
with fibroblasts or alone in EGM-2 MV growth medium. The
thinner structures in these networks covered less of the total
area. Interestingly, by combining fibroblast coculture with
the supplemented growth factors, we were able to achieve
the larger coverage area and network stability provided by
fibroblast coculture, while maintaining the reduced diame-
ters and average length induced by the angiogenic growth
factors.
Fibrin concentration
Fibrin gel was chosen for our experiments due to its bio-
logical relevance during tissue regrowth at wound healing
sites and its unique mechanical properties. Specifically, fibrin
gel demonstrates strain stiffening, which allows it to be
easily deformed by network forming ECs at small strains,
while maintaining its overall structural stability at the net-
work level.22 It is capable of undergoing large, recoverable
deformations and can withstand considerably large strains
before rupture.23–25 We chose to alter the mechanical prop-
erties of our fibrin gel by varying the fibrinogen concentra-
tion from 1.5 to 10mg/mL. The fibrinogen concentration is a
key determining factor of the mechanical structure and
strength of fibrin gels and has been shown to influence MVN
formation.26,27 We found that the number of branches in a
network was highly sensitive to the fibrinogen concentration,
while the coverage area remained little changed over the
entire range of concentrations studied. Both the average
branch length and effective diameter decreased with in-
creasing fibrinogen concentrations (Fig. 4). The change in
effective diameter between the two extreme conditions was
17.1% – 4.6%.
HUVEC seeding density
We found that HUVEC seeding density plays an im-
portant role in MVN formation and the resulting network
morphology. At a HUVEC seeding density of one million
cells/mL, we found that sparse networks formed with
comparatively short branches and small diameters. This
represents the lowest seeding density achievable, beyond
which perfusable MVNs will not form. With increasing
seeding density, we found that the branch length, diameter,
and area fraction of the vascularized region all increased
(Fig. 5).
FIG. 3. (A) Representative binary
images of MVNs formed under
conditions of endothelial cell (EC)
monoculture in EGM-2 MV medi-
um; EC + Fibroblast (FB) noncontact
coculture in EGM-2 MV medium;
EC monoculture with EGM-2 MV
medium supplemented with vas-
cular endothelial growth factor
(VEGF) (50 ng/mL) and sphingo-
sine-1-phosphate (S1P) (250 nM);
EC + FB noncontact coculture in
EGM-2 MV medium supplemented
with VEGF and S1P. Fixed net-
works were stained with phalloidin
and ImageJ was used to process
and binarize fluorescent images.
One image from each condition was
chosen arbitrarily to represent the
group. (B) Number of branches per
mm2 of vascularized region. Values
given are averages over three de-
vices with error bars given as stan-
dard error (same for C–E). (C)
Average branch length of MVN. (D)
Percentage of area covered by per-
fusable MVN. (E) Effective diameter
of vessels in engineered MVN, cal-
culated as the ratio of vascularized
area to total length of engineered
MVN; GF, growth factor.
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Fibroblast seeding density
The fibroblasts in our system are physically separated
from the HUVECs and their effect on MVN formation is
through paracrine signaling. We tested to see whether the
amount of fibroblasts cultured in the stromal cell gel region
had a significant impact on the engineered MVN morphol-
ogy. Holding the HUVEC seeding density constant at 4
million cells/mL, we varied the amount of fibroblasts seeded
from one half to twice the amount of HUVECs seeded. We
found no significant differences in any of the measured MVN
parameters (data not shown). Interestingly, we found that
the stabilizing effect—as measured by the percentage of
perfusable segments at day 6—was dose dependent on the
amount of fibroblasts present and reached a steady maxi-
mum value at a HUVEC:HLF ratio of 1:1 (Fig. 2C).
Discussion
The ultimate goal of tissue engineering is to replace ailing
tissues and failing organs in vivo. It has been increasingly
realized that forming prevascularized tissue in vitromay be a
necessary first step.15,28,29 Additionally, in vitro platforms
enabling the growth and maintenance of a functional mi-
crovasculature provide significant benefits in their own right.
Perfusable, in vitro models can be used as physiological
drug-screening platforms for developing and identifying
metastasis preventing cancer drugs.30,31 As demonstrated
here, the system can be used to isolate the environmental
factors influencing MVN formation and to study their effects.
This is an important step in continuing to develop tissue
engineering as a quantitative science and to enhance control
in the design of tissue-engineered constructs. Whereas the
present experiments have been performed in an in vitro
system, not intended for in vivo use, we anticipate that the
design principles we discovered would apply for other,
similar tissue-engineered constructs. Alternatively, by non-
permanently sealing the device with a second layer of
PDMS—rather than a glass coverslip—we can successfully
remove the vascularized hydrogel after it forms. The re-
moved constructs could potentially be implanted directly
in vivo.
We successfully formed MVNs using our system con-
taining vessels with diameters ranging between 1 and
100 mm. These vessels form complex, interconnected net-
works and are perfusable. It is known that the flow charac-
teristics of blood perfusing through the vasculature is
important in determining and maintaining network mor-
phology. In one in vitro study, it was found that interstitial
flow during vasculogenesis was necessary to form perfusable
MVNs.11 This was not the case for our system in which
FIG. 4. (A) Representative
binary images of MVNs
formed under conditions of
increasing fibrinogen concen-
tration for fibrin gel cell en-
capsulation experiments. One
image from each condition
was chosen arbitrarily to
represent the group. Fixed
networks were stained with
phalloidin; ImageJ was used
to process and binarize fluo-
rescent images. (B) Number
of branches per mm2 of vas-
cularized region. Values
given are averages over three
to four devices with error
bars given as standard error
(same for C–E). (C) Average
branch length of MVN. (D)
Percentage of area covered by
perfusable MVN. (E) Effective
diameter of vessels in en-
gineered MVN, calculated as
the ratio of vascularized area
to total length of engineered
MVN.
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perfusable networks formed in the absence of flow. How-
ever, it is plausible that interstitial flow might affect the
dynamics of network formation and the resulting morphol-
ogy. Interstitial flow has been shown to affect cancer cell
migration32 and angiogenic sprouting through an integrin-
mediated sensing mechanism,33 which may also be impor-
tant during vasculogenic network formation. In this study,
we focused on preflow factors and showed that they direct
the early stages of MVN formation in vasculogenesis. In
future studies, it will be interesting to study the relative
importance of flow through the networks after initial
formation as it is also likely to play an important role. Flow-
induced shear stress sensed by the endothelium acts to reg-
ulate the diameter of blood vessels in vivo.34 It also leads to
the pruning of extraneous branches eventually directing the
vascular network morphology toward an energetically op-
timal pattern.35,36 We would expect that similar phenomena
would occur in our system with the addition of flow. This
could be confirmed by introducing tracer particles into the
networks to visualize the flow field and correlating regions
of pruned vessels to regions of limited flow. The presence of
chronic shear flow36 and the introduction of stabilizing
pericytes37,38 would also provide a more authentically native
microvascular environment and would likely lead to net-
work morphologies that more closely mimic those found
in vivo.
In designing vascularized tissue, it is important to consider
that, in vivo, ECs form vascular networks within a complex
environment involving dynamic heterotypical interactions. In
addition to mechanical and signaling cues provided by the
surrounding extracellular matrix, communication with sup-
porting cell types is critical.39,40 Our microfluidic system al-
lows for spatial segregation of various cell types in a compact
environment enabling communication through the diffusion
FIG. 5. (A) Representative binary
images of MVNs formed under
conditions of increasing human
umbilical vein endothelial cell
(HUVEC) seeding density. One im-
age from each condition was chosen
arbitrarily to represent the group.
Fixed networks were stained with
phalloidin and ImageJ was used to
process and binarize fluorescent
images. (B)Number of branches per
mm2 of vascularized region. Values
given are averages over three de-
vices with error bars given as stan-
dard error (same for C–E). (C)
Average branch length of MVN. (D)
Percentage of area covered by per-
fusable MVN. (E) Effective diameter
of vessels in engineered MVN, cal-
culated as the ratio of vascularized
area to total length of engineered
MVN.
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of soluble factors. By culturing the two cell types together in a
single gel region, we could also study the potential stabilizing
effects due to cell–cell contact and juxtracrine signaling be-
tween the two cell types and fibroblast remodeling of the
ECM. It has been shown that the stabilizing effects of MSCs
onMVN formation in vitro depend on the time at whichMSCs
are introduced into the mixed coculture system. Interestingly,
MSCs only promoted network stability when introduced at
least 24 h after EC seeding.41 Seeding two cell types simulta-
neously in the same gel would presumably alter the chemical
gradient profiles, lead to a competition for local nutrients
and cytokines, and affect the structural properties of the
ECM in which ECs are forming a vascular network.
The stabilizing effect of fibroblasts in our noncontact co-
culture system was striking. Without HLFs, the nascent EC
networks quickly regressed after initial formation. However,
through communication with HLFs, these nascent networks
were able to maintain a stable morphology and level of
perfusability. These results are in agreement with those
found by Kim et al.,10 in which a lumenized vasculature was
lacking after 4 days of EC culture without fibroblasts present.
Our results further elucidate that vascular networks do ini-
tially form, but subsequently regress in the absence of a
second cell type. It has been shown that fibroblasts enhance
MVN formation through direct paracrine signaling20 and
also by adapting the ECM through secreted molecules.21 It
will be interesting in future studies to observe the ECM in
real time during MVN formation to characterize this process.
It will also be useful to test the effects of various other
stromal cells and determine their efficacy in MVN formation
for use in regenerative cell therapies.
An important finding from our study is that factors se-
creted from fibroblasts affect the processes of (a) network
formation and (b) stabilization independently. When HU-
VECs were cultured with HLFs alone, the networks formed
with a larger diameter than the control condition and
maintained perfusability through day 6. HUVECs cultured
with VEGF and S1P formed networks with a smaller diam-
eter and regressed with time. Combining HLF coculture with
VEGF and S1P produced networks with smaller diameters
FIG. 6. (A) Diagram of de-
sign approach to microvas-
cular tissue engineering. Use
of microfluidic platform to
quantify effects of mechanical
and chemical stimuli on re-
sulting network morphology.
Novel, noncontact multi-
culture system to study cell–
cell communication and net-
work stabilization. (B) Range
of network parameters
achievable through control of
inputs studied. (C) Table of
the effects of tunable inputs
on distinct network morpho-
logical parameters.
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that remained stable. This suggests that different growth
factors might independently control the individual charac-
teristics of network morphology and that this process is also
independent of network stabilization. Future work will ex-
plore the individual effects of specific growth factors known
to be involved in vasculogenesis.
We produced a table of results (Fig. 6), which captures our
design approach to microvascular engineering and summa-
rizes our findings. In this study, we mapped out the design
space for the creation ofMVNswith prescribedmorphological
properties. The controllable inputs we studied were cell
seeding densities, ECM composition, and paracrine signaling
factors. The output metrics we analyzed were the number of
branches, average branch length, area fraction of vasculari-
zation, and effective diameter. These properties proved suffi-
cient to quantitatively describe the significant differences in
network morphology observed by varying environmental
conditions. The list of environmental factors studied here is
not exhaustive, and future work will utilize this system and
approach to expand in both breadth and depth. Additionally,
to further probe the mechanisms underlying the observations
found in this study, it would be useful to pair these experi-
ments with a computational modeling approach.42–44 In clos-
ing, this study provides a significant contribution to the effort
of quantifying the science of microvascular tissue engineering
and creating MVNs with prescribed morphological properties
for tissue-specific applications.
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